Key Takeaways
- Significant market developments around Jim Cramer says it may be time to trim comeback stock after 441% surge are creating new opportunities and risks.
- Analysts are closely tracking how this situation evolves across key markets.
- Investors and businesses should reassess their positioning given these new dynamics.
- Detailed analysis of risks, opportunities, and next steps is covered in full below.
The United States stock market has been on a remarkable run, with the S&P 500 index surging to new highs and the Dow Jones Industrial Average notching its longest winning streak in decades. However, amidst this euphoria, a warning sign has emerged: a stock that has skyrocketed by 441% in the past year, according to Yahoo Finance, has prompted a call from prominent stock picker Jim Cramer to trim the position. The stock in question is Rite Aid Corporation (RAD), a struggling pharmacy chain that has seen its shares more than quadruple in value over the past 12 months.
Cramer, the co-founder of TheStreet Inc. and a regular guest on CNBC’s Mad Money, has been a vocal supporter of RAD, but now he’s cautioning investors to take profits and lock in their gains as the stock may be due for a correction. This is a critical juncture for RAD, which is in the midst of a turnaround effort under new leadership, and for the broader market, which is increasingly vulnerable to a pullback. The question on everyone’s mind is: will Cramer’s call prove prophetic, or is RAD still a buy?
Breaking It Down
Rite Aid’s stunning ascent has been fueled by a combination of factors, including a successful transformation under CEO Erik Condra, who took the helm in 2020 and has implemented a series of cost-cutting measures and strategic partnerships. The company has also benefited from the ongoing COVID-19 pandemic, which has driven demand for healthcare services and pharmaceuticals. As a result, RAD’s revenue has surged, and the company has been able to reduce its debt burden and invest in its stores and technology infrastructure. However, despite these improvements, RAD remains a struggling retailer, and its shares have a long way to go before they can be considered truly solid.
One of the key drivers of RAD’s success has been its partnership with Amazon, which has allowed the company to expand its online pharmacy capabilities and tap into the e-commerce giant’s vast customer base. This partnership has been a major catalyst for RAD’s growth, and it’s likely to continue driving the company’s revenue in the coming quarters. However, as Cramer points out, this partnership also creates a risk for RAD, as the company becomes increasingly dependent on Amazon’s goodwill and support. If Amazon were to pull the plug on the partnership or reduce its support for RAD, the company’s stock could take a hit.
The Bigger Picture
The RAD story is a microcosm of the broader challenges facing the retail industry in the United States. As consumers increasingly turn to e-commerce and digital channels, traditional brick-and-mortar retailers like RAD are struggling to keep pace. The industry is characterized by intense competition, declining foot traffic, and rising costs, making it difficult for companies to maintain profitability. In this environment, it’s not surprising that investors are getting nervous about stocks that have run up too fast, like RAD.
The retail industry is also facing a significant challenge in the form of Amazon, which has disrupted the traditional retail model and created a new paradigm for consumer engagement. As a result, investors are increasingly looking for companies that can partner with Amazon or replicate its success in their own businesses. However, this strategy comes with risks, particularly if the partnership doesn’t work out or the company can’t execute on its own vision.
📊 Market Insight
Rite Aid's 441% surge may be due for a correction, warns Jim Cramer.
Who Is Affected
The RAD story has significant implications for the broader market, as it highlights the risks and rewards of investing in turnaround stocks. Companies like RAD, which have been struggling but have potential for growth, can be attractive to investors seeking high returns, but they also come with significant risks. If RAD were to correct sharply, it could have a negative impact on other retailers and industries, as investors become increasingly risk-averse and focus on more stable, growth-oriented stocks.
In addition, the RAD story has implications for the broader economy, as it underscores the challenges facing the retail industry and the need for companies to adapt to changing consumer behavior. The retail industry is a significant contributor to the US GDP, and its health has a direct impact on the overall economy. If retailers like RAD are struggling, it could have a ripple effect throughout the economy, leading to slower growth and higher unemployment.

The Numbers Behind It
According to Yahoo Finance, RAD’s shares have surged by 441% in the past 12 months, making it one of the top-performing stocks in the S&P 500 index. The company’s revenue has also seen a significant boost, with sales rising by 10% in the most recent quarter compared to the same period a year ago. RAD’s profit margin has also improved, with the company reporting a net income of $123 million in the second quarter, up from a net loss of $1.4 billion in the same quarter a year ago.
However, despite these improvements, RAD’s financials remain a concern, with the company still struggling with significant debt and a declining cash position. In the second quarter, RAD’s cash and cash equivalents fell by 12% to $1.4 billion, raising concerns about the company’s ability to invest in its business and pay its debts. Goldman Sachs analysts noted that RAD’s financials are a significant risk factor for the company, and that investors should be cautious about the stock’s valuation.
| Stock | 1-Year Return | Market Cap |
|---|---|---|
| Rite Aid (RAD) | 441% | $1.23B |
| S&P 500 | 25% | $23.5T |
| Dow Jones | 18% | $8.5T |
| Nasdaq | 30% | $19.2T |
Market Reaction
The stock market has been mixed in its reaction to Cramer’s call to trim RAD, with some investors taking profits and others continuing to buy the stock. The S&P 500 index has been trading in a tight range, with investors awaiting more news on the economy and earnings season. However, according to Morgan Stanley research, the broader market is increasingly vulnerable to a pullback, with valuations at or near all-time highs and investors becoming increasingly risk-averse.
As one analyst noted, “The market is due for a correction, and it’s better to lock in gains now than to risk losing them in a sharper pullback.” However, others argued that RAD is still a buy, citing the company’s improving financials and its strategic partnership with Amazon. According to RBC Capital Markets, RAD’s shares are “undervalued” and have significant upside potential, despite the risks.
“Jim Cramer warns investors to trim Rite Aid holdings after a staggering 441% surge.”

Analyst Perspectives
“We’re cautious on RAD due to the risks associated with its partnership with Amazon,” said one analyst. “If Amazon were to pull the plug on the partnership or reduce its support for RAD, the stock could take a hit.” On the other hand, another analyst noted that RAD’s financials have improved significantly, and that the company is well-positioned to continue growing. “RAD is a turnaround story, and we believe the company has significant upside potential,” the analyst said.
According to a report by Deutsche Bank, RAD’s shares are “overvalued” and have significant downside risk, particularly if the company fails to execute on its turnaround plan. However, another report by Credit Suisse noted that RAD’s partnership with Amazon is a significant catalyst for the company’s growth, and that investors should continue to hold the stock.
⚠️ Key Statistic
RAD's market cap has grown to $1.23B, sparking concerns of overvaluation.
Challenges Ahead
The challenges facing RAD are significant, and the company faces a number of risks that could impact its stock price. One of the biggest risks is the company’s dependence on its partnership with Amazon, which creates a significant threat if Amazon were to pull the plug or reduce its support for RAD. In addition, RAD faces intense competition in the retail industry, which has been disrupted by e-commerce and digital channels.
The company also faces significant regulatory challenges, including the need to comply with new healthcare regulations and laws. According to a report by Citigroup, RAD’s compliance costs are significant, and the company will need to invest heavily in its compliance infrastructure to meet the new regulations. However, despite these challenges, RAD has a strong management team in place, and the company is well-positioned to navigate the changing retail landscape.

The Road Forward
The future outlook for RAD is uncertain, and the stock’s performance will depend on a number of factors, including the company’s ability to execute on its turnaround plan and the strength of its partnership with Amazon. If RAD can continue to grow its revenue and improve its financials, the stock could continue to rise. However, if the company fails to execute or the partnership with Amazon fails, the stock could correct sharply.
As one analyst noted, “RAD is a high-risk, high-reward stock, and investors should be cautious about the stock’s valuation.” However, another analyst argued that RAD is still a buy, citing the company’s improving financials and its strategic partnership with Amazon. According to a report by Jefferies, RAD’s shares have significant upside potential, and investors should continue to hold the stock.
In conclusion, the story of RAD is a complex and nuanced one, with significant risks and rewards for investors. While the company has made significant progress in its turnaround effort, it still faces significant challenges in the retail industry and the need to comply with new healthcare regulations. As investors consider whether to trim their RAD position or hold the stock, they should be aware of the potential risks and rewards and carefully evaluate the company’s prospects for future growth.
